ES2912499T3 - Miméticos de tiodisacáridos a base de tetrahidropirano como inhibidores de galectina-3 - Google Patents

Miméticos de tiodisacáridos a base de tetrahidropirano como inhibidores de galectina-3 Download PDF

Info

Publication number
ES2912499T3
ES2912499T3 ES19740100T ES19740100T ES2912499T3 ES 2912499 T3 ES2912499 T3 ES 2912499T3 ES 19740100 T ES19740100 T ES 19740100T ES 19740100 T ES19740100 T ES 19740100T ES 2912499 T3 ES2912499 T3 ES 2912499T3
Authority
ES
Spain
Prior art keywords
mmol
pyran
tetrahydro
triazol
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19740100T
Other languages
English (en)
Spanish (es)
Inventor
Richard A Hartz
Li Xu
David S Yoon
Alicia Regueiro-Ren
Prasada Rao Jalagam
Manoranjan Panda
Satheesh Kesavan Nair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2912499T3 publication Critical patent/ES2912499T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES19740100T 2018-06-15 2019-06-13 Miméticos de tiodisacáridos a base de tetrahidropirano como inhibidores de galectina-3 Active ES2912499T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862685395P 2018-06-15 2018-06-15
US201962831867P 2019-04-10 2019-04-10
PCT/US2019/036877 WO2019241461A1 (en) 2018-06-15 2019-06-13 Tetrahydropyran-based thiodisaccharide mimics as galectin-3 inhibitors

Publications (1)

Publication Number Publication Date
ES2912499T3 true ES2912499T3 (es) 2022-05-26

Family

ID=67297250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19740100T Active ES2912499T3 (es) 2018-06-15 2019-06-13 Miméticos de tiodisacáridos a base de tetrahidropirano como inhibidores de galectina-3

Country Status (7)

Country Link
US (1) US11970511B2 (cg-RX-API-DMAC10.html)
EP (1) EP3807290B1 (cg-RX-API-DMAC10.html)
JP (1) JP7190513B2 (cg-RX-API-DMAC10.html)
KR (1) KR102802503B1 (cg-RX-API-DMAC10.html)
CN (1) CN112292386B (cg-RX-API-DMAC10.html)
ES (1) ES2912499T3 (cg-RX-API-DMAC10.html)
WO (1) WO2019241461A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113366007A (zh) * 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
CN113286632A (zh) * 2018-10-15 2021-08-20 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂前药
US12275720B2 (en) * 2020-05-05 2025-04-15 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
CN115768768A (zh) 2020-05-28 2023-03-07 百时美施贵宝公司 半乳凝素-3抑制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
ES2652488T3 (es) 2009-04-28 2018-02-02 Galecto Biotech Ab Nuevos inhibidores de galactósidos de galectinas
JP2014518267A (ja) 2011-06-27 2014-07-28 杏林製薬株式会社 細菌感染症の治療のための架橋二環式化合物
US9021050B2 (en) 2012-08-31 2015-04-28 Yume, Inc. Network service system and method with off-heap caching
KR102231732B1 (ko) 2012-10-10 2021-03-23 갈렉틴 테라퓨틱스, 인크. 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물
IN2015DN02573A (cg-RX-API-DMAC10.html) * 2012-10-31 2015-09-11 Galecto Biotech Ab
EP2919802A4 (en) 2012-11-15 2016-09-14 Univ Tufts METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER
JP6735680B2 (ja) 2014-07-09 2020-08-05 ガレクト バイオテック エービー ガレクチンの新規ハイブリッドガラクトシド阻害剤
CA2970062C (en) 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CA3000924A1 (en) 2015-11-09 2017-05-18 Galecto Biotech Ab Novel galactoside inhibitors of galectins
JP6844991B2 (ja) 2015-11-10 2021-03-17 サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスSanko Tekstil Isletmeleri San. Ve Tic. A.S. ジッパーを有する伸縮性衣類の製法

Also Published As

Publication number Publication date
US11970511B2 (en) 2024-04-30
EP3807290B1 (en) 2022-03-30
KR102802503B1 (ko) 2025-04-29
WO2019241461A1 (en) 2019-12-19
JP7190513B2 (ja) 2022-12-15
KR20210021015A (ko) 2021-02-24
US20210323991A1 (en) 2021-10-21
CN112292386B (zh) 2024-06-11
EP3807290A1 (en) 2021-04-21
CN112292386A (zh) 2021-01-29
JP2021527102A (ja) 2021-10-11

Similar Documents

Publication Publication Date Title
US11072626B2 (en) Small molecule inhibitors of Galectin-3
JP2024540410A (ja) Kras g12c阻害剤
CN107148423B (zh) 硫代核苷衍生物或其盐及医药组合物
KR20220071193A (ko) Kras g12d 억제제
TWI785474B (zh) 用作選擇性Aurora A抑制劑的新型雜環化合物
KR102802503B1 (ko) 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체
ES2984075T3 (es) Inhibidores de moléculas pequeñas de galectina-3
KR20180094514A (ko) 브루톤 티로신 키나제 억제제 및 이의 사용 방법
EP4413004A1 (en) Macrocyclic compounds having ent1 inhibiting activity
TWI651325B (zh) 作為cam激酶抑制劑之稠合雜環化合物
US12275720B2 (en) Small molecule inhibitors of galectin-3
WO2020117883A1 (en) Small molecule inhibitors of galectin-3
EA052559B1 (ru) Конденсированные гетероарильные соединения и их применение в качестве ингибиторов camkii
HK1235794A1 (en) Thionucleoside derivative or salt thereof, and pharmaceutical composition
HK1208439B (en) 5-azaindazole compounds and methods of use